High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).

Lascombes, F; Sommelet, D; Gebhard, F; Leverger, G.; Schaison, R; Pinkerton, R.; Bosly, André; Patte, C.; Boos, J; Smedmyr, B; Lederlin, P.; Stryckmans, P.

High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS).

Lascombes, F

;

Sommelet, D

;

Gebhard, F

;

Leverger, G.

;

Stryckmans, P.

;et.al.

(1998)

Files

No attached file found for this publication.

Details

Authors

Lascombes, F
Author
Sommelet, D
Author
Gebhard, F
Author
Leverger, G.
Author
Bosly, AndréUCLouvain
Author
Stryckmans, P.
Author

Affiliations

UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Lascombes, F., Sommelet, D., Gebhard, F., Leverger, G., Schaison, R., Pinkerton, R., Bosly, A., Patte, C., Boos, J., Smedmyr, B., Lederlin, P., & Stryckmans, P. (1998). High efficacy of recombinant urate oxidase in prevention of renal failure related to tumor lysis syndrome (TLS). Blood, 92(10), 237B-237B. (Original work published 1998)